Clinical Trials on Suspected or Documented Gram-negative Bacterial Infection

Total 4905 results

Shionogi

Approved for marketing

Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections

Bacterial Infections
Pfizer

Completed

A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

MENINGOCOCCAL INFECTION

Finland, Poland
Pfizer

Completed

Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose

Meningococcal Infection

United States, Finland, Czechia, Sweden, Denmark, Germany
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

Meningococcal Infection

Germany
Epicentre
Massachusetts General Hospital; Médecins Sans Frontières, Belgium; Ministry of...

Active, not recruiting

Immune Response to a Delayed Second Dose of Oral Cholera Vaccine

Cholera | Vibrio Cholerae Infection

Guinea
Johns Hopkins Bloomberg School of Public Health

Completed

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Cholera | Vibrio Cholerae Infection

Zambia
Sohag University

Recruiting

Clinical Utility of Upper Endoscopy in Diagnosis of Helicobacter Pylori Infection

Helicobacter Pylori Infection

Egypt
Nanjing First Hospital, Nanjing Medical University

Recruiting

The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu

Helicobacter Pylori Infection

China
Poitiers University Hospital

Recruiting

New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non-invasive PCR in Stool

Helicobacter Pylori Infection

France
Shandong University

Not yet recruiting

Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection

Helicobacter Pylori Infection
The Third Xiangya Hospital of Central South University
The Second People's Hospital of Huaihua; Yueyang Hospital of Traditional Chinese...

Completed

Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
TenNor Therapeutics Inc.

Completed

A Phase 1, Multiple Oral Administrations of TNP-2092 Capsules in Asymptomatic Healthy People With Helicobacter Pylori Infection

Helicobacter Pylori Infection
Indonesia University

Completed

Rapid Urease Test for Diagnosis Helicobacter Pylori Infection

Helicobacter Pylori Infection

Indonesia
Universiti Kebangsaan Malaysia Medical Centre
Y.S.P. Industries (M) Sdn. Bhd, Menara LGB, Taman Tun Dr Ismail, 60000 Kuala...

Completed

The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adults

Helicobacter Pylori Infection

Malaysia
Phathom Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection

Helicobacter Pylori Infection

United States, Hungary, Poland, Bulgaria, United Kingdom, Czechia
Incheon St.Mary's Hospital

Active, not recruiting

Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Korea, Republic of
Assiut University

Unknown

The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital

Helicobacter Pylori Infection
Shandong University

Unknown

Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Shandong University

Unknown

A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Indonesia University

Unknown

10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication

Helicobacter Pylori Infection

Indonesia
Zagazig University
BioGaia AB

Completed

Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients

Helicobacter Pylori Infection

Egypt
Chuncheon Sacred Heart Hospital

Terminated

Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection

Helicobacter Pylori Infection

Korea, Republic of
University of Campania "Luigi Vanvitelli"

Completed

5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection

Helicobacter Pylori Infection

Italy
National Taiwan University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Completed

Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBT

H. Pylori Infection

Taiwan
Jilin University

Recruiting

White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection

Helicobacter Pylori Infection

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Shandong University
Zibo Central Hospital; Peking University Care Luzhong Hospital; Yuncheng Traditional... and other collaborators

Not yet recruiting

The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Shandong University
The First Affiliated Hospital of Zhengzhou University; Zibo Central Hospital; Peking University Care Luzhong Hospital and other collaborators

Not yet recruiting

The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Alexandria University

Recruiting

Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management

Helicobacter Pylori Infection

Egypt
Nanfang Hospital of Southern Medical University

Not yet recruiting

A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection
Shandong University

Not yet recruiting

14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
The Third Xiangya Hospital of Central South University

Recruiting

Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Peking University First Hospital
Peking University International Hospital; Beijing Geriatric Hospital; Beijing...

Recruiting

Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Kyunghee University Medical Center

Unknown

Dual-focus Magnification With Narrow-band Imaging in Helicobacter Pylori Infection

Helicobacter Pylori Infection

Korea, Republic of
National Taiwan University Hospital

Completed

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

Helicobacter Pylori Infection

Taiwan
Mackay Memorial Hospital

Completed

Intraluminal Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Southwest Oncology Group
University of Michigan; Hope Foundation

Completed

S1119 Peruvian H. Pylori Water Contamination Study

Helicobacter Pylori Infection

Peru
Samsung Medical Center

Unknown

Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Korea, Republic of
Seoul National University Bundang Hospital
Ministry of Education, Republic of Korea (2012R1A1A3A04002680)

Completed

15-day Sequential Therapy for Helicobacter Pylori Infection in Korea

Helicobacter Pylori Infection

Korea, Republic of
Catholic University of the Sacred Heart

Unknown

Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study

Helicobacter Pylori Infection

Italy
TenNor Therapeutics (Suzhou) Limited

Completed

Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection

H.Pylori Infection

China
Manuel Coelho da Rocha

Not yet recruiting

Tailored vs. Empirical Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

Portugal
Shanghai Zhongshan Hospital

Recruiting

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

China
Second Affiliated Hospital of Xi'an Jiaotong University

Recruiting

Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

Helicobacter Pylori Infection

China
University Hospital Freiburg

Recruiting

Pathogen-microbiome Interaction During Helicobacter Pylori Infection (PREDICTHP)

Helicobacter Pylori Infection

Germany
Hamdard University

Completed

Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori Infection

H. Pylori Infection

Pakistan
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Centre Hospitalier Universitaire, Amiens

Completed

Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic (BHReICU)

Enterobacteriaceae Infections | Hospital-Acquired Infection

France
Federal State Budgetary Scientific Institution...
St. Petersburg State Pavlov Medical University; Moscow Clinical Scientific... and other collaborators

Completed

Helicobacter Pylori Infection Occurrence in Russia

Helicobacter Pylori Infection

Russian Federation
Antonio Mestrovic
University Hospital of Split; University of Split, School of Medicine

Completed

Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.

Helicobacter Pylori Infection

Croatia

Clinical Trials on Suspected or Documented Gram-negative Bacterial Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations